Between 2012 and 2022, the insulin in dosage market in Poland experienced significant fluctuations. The market demonstrated growth spurts in early years such as 2014 with a 9.36% year-on-year increase, but faced sharp declines in subsequent years like 2015 and 2016 with decreases of 18.72% and 20.96%, respectively. Stabilization occurred slowly, with minor positive variations in 2020 and 2021, though the market dipped by 12.58% in 2022. Over the last five years, the compound annual growth rate (CAGR) was -3.86%. In 2023, the market value is uncertain, awaiting final data, yet the trend suggests a potential further decline or plateau.
Looking to the future, notable trends to watch include:
- Potential for market stabilization or modest growth as the industry adapts to innovations in insulin delivery technology.
- Impact of healthcare policies and diabetes management programs on market demand.
- Shifts due to economic conditions affecting healthcare spending in Poland.
How does Poland rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 9 | 9 Netherlands | 431,700,000 | 2023 | +3.4% | -0.08% | View data |
| 10 | 10 Czech Republic | 331,020,000 | 2023 | +1.22% | +0.83% | View data |
| 11 | 11 Poland | 308,530,000 | 2023 | -3.91% | -4.34% | |
| 12 | 12 Greece | 290,110,000 | 2023 | +5.75% | +6.69% | View data |
| 13 | 13 Belgium | 260,730,000 | 2023 | +2.7% | +3.78% | View data |
